Meeting
2018 ASCO Annual Meeting
Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial.
Authors
Judy Caroline Boughey
Mayo Clinic, Rochester, MN
Judy Caroline Boughey , Karla V. Ballman , Linda Mackie McCall , Henry Mark Kuerer , Kelly Hunt , Jane M. Armer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Clinical Trial Registration Number
NCT00881361
Citation
J Clin Oncol 36, 2018 (suppl; abstr 513)
DOI
10.1200/JCO.2018.36.15_suppl.513
Abstract #
513
Poster Bd #
5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Risk assessment, prevention and early detection of breast cancer related lymphedema: Objective measurements and patient reported outcomes.
First Author: Anshumi Desai
Poster
2024 ASCO Annual Meeting
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (OPBC-03/SAKK 23/16/IBCSG 57-18/ABCSG-53/GBG-101-TAXIS).
First Author: Walter Paul Weber
Poster
2024 ASCO Annual Meeting
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
First Author: Maggie Banys-Paluchowski
Poster
2023 ASCO Annual Meeting
Association of minimizing the false negative rate of axillary staging surgery in patients with cN1 breast cancer after neoadjuvant chemotherapy with surgical overtreatment.
First Author: Alison Laws